Circulating intermediate monocytes and toll-like receptor 4 correlate with low-voltage zones in atrial fibrillation

被引:0
|
作者
Hideya Suehiro
Koji Fukuzawa
Naofumi Yoshida
Kunihiko Kiuchi
Mitsuru Takami
Tomomi Akita
Tokiko Tabata
Makoto Takemoto
Jun Sakai
Toshihiro Nakamura
Atsusuke Yatomi
Hiroyuki Takahara
Yusuke Sonoda
Kazutake Nakasone
Kyoko Yamamoto
Atsushi Suzuki
Tomoya Yamashita
Ken-ichi Hirata
机构
[1] Kobe University Graduate School of Medicine,Division of Cardiovascular Medicine, Department of Internal Medicine
[2] Kobe University Graduate School of Medicine,Section of Arrhythmia, Division of Cardiovascular Medicine, Department of Internal Medicine
[3] Osaka Saiseikai Nakatsu Hospital,Division of Cardiology
来源
Heart and Vessels | 2020年 / 35卷
关键词
Intermediate monocytes; Toll-like receptor 4; Low-voltage zones; Inflammation; Atrial fibrillation;
D O I
暂无
中图分类号
学科分类号
摘要
Inflammation has been suggested to play a key role in the pathogenesis of atrial fibrillation (AF). Our hypothesis was that this inflammation, mediated by intermediate monocytes and toll-like receptor 4 (TLR4), causes the formation and expansion of low-voltage zones (LVZs). Prior to ablation, the monocyte subsets of 78 AF patients and TLR4 expression of 66 AF patients were analyzed via a flow cytometric analysis. Based on the CD14/CD16 expression, the monocytes were divided into three subsets: classical, intermediate, and non-classical. At the beginning of the ablation session, voltage mapping was performed. LVZs were defined as all bipolar electrogram amplitudes of < 0.5 mV. Correlations between the flow cytometric analysis results and presence of LVZs, as well as the total area of the LVZ, were examined. Patients with LVZs clearly had a higher proportion of intermediate monocytes (10.0 ± 3.6% vs. 7.2 ± 2.7%, p < 0.001) than those without LVZs. TLR4 was much more frequently expressed in the intermediate monocytes than other two monocyte subsets (p < 0.001). Moreover, the TLR4 expression level in intermediate monocytes correlated positively with the total area of the LVZs (r = 0.267, p = 0.030), especially in patients with paroxysmal AF (r = 0.365, p = 0.015). The intermediate monocytes and TLR4 expression positively correlated with LVZs in AF patients.
引用
收藏
页码:1717 / 1726
页数:9
相关论文
共 50 条
  • [1] Circulating intermediate monocytes and toll-like receptor 4 correlate with low-voltage zones in atrial fibrillation
    Suehiro, Hideya
    Fukuzawa, Koji
    Yoshida, Naofumi
    Kiuchi, Kunihiko
    Takami, Mitsuru
    Akita, Tomomi
    Tabata, Tokiko
    Takemoto, Makoto
    Sakai, Jun
    Nakamura, Toshihiro
    Yatomi, Atsusuke
    Takahara, Hiroyuki
    Sonoda, Yusuke
    Nakasone, Kazutake
    Yamamoto, Kyoko
    Suzuki, Atsushi
    Yamashita, Tomoya
    Hirata, Ken-ichi
    HEART AND VESSELS, 2020, 35 (12) : 1717 - 1726
  • [2] Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes
    Bernhard, J.
    Engelberger, K.
    Galli, L.
    Haider, P.
    Ungersbaeck, K.
    Hengstenberg, C.
    Speidl, W. S.
    Krychtiuk, K. A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [3] Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes
    Bernhard, J.
    Engelberger, K.
    Galli, L.
    Haider, P.
    Ungersbaeck, K.
    Hengstenberg, C.
    Speidl, W. S.
    Krychtiuk, K. A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S417 - S417
  • [4] Monocyte Toll-Like Receptor Expression in Patients With Atrial Fibrillation
    Gurses, Kadri Murat
    Kocyigit, Duygu
    Yalcin, Muhammed Ulvi
    Canpinar, Hande
    Yorgun, Hikmet
    Sahiner, Mehmet Levent
    Kaya, Ergun Buis
    Oto, Mehmet Ali
    Ozer, Necla
    Guc, Dicle
    Aytemir, Kudret
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (09): : 1463 - 1467
  • [5] Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
    Guriec, Nathalie
    Bussy, Frederick
    Gouin, Christelle
    Mathiaud, Olivier
    Quero, Benoit
    Le Goff, Matthieu
    Collen, Pi Nyvall
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [6] Increased platelet toll-like receptor-2 and 4 expression in atrial fibrillation
    Gurses, K. M.
    Kocyigit, D.
    Yalcin, M. U.
    Canpinar, H.
    Evranos, B.
    Tokgozoglu, L.
    Oto, M. A.
    Guc, D.
    Ozer, N.
    Aytemir, K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1077 - 1077
  • [7] Expansion of circulating toll-like receptor 4-positive monocytes in patients with acute coronary syndrome
    Methe, H
    Kim, JO
    Kofler, S
    Weis, M
    Nabauer, M
    Koglin, J
    CIRCULATION, 2005, 111 (20) : 2654 - 2661
  • [8] Low-Voltage Zones as the Atrial Fibrillation Substrates: Relationship With Initiation, Perpetuation, and Termination
    Liu, Zheng
    Xia, Yu
    Guo, Changyan
    Li, Xiaofeng
    Fang, Pihua
    Yin, Xiandong
    Yang, Xinchun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] Toll-like receptor 9 is a novel therapeutic target to prevent atrial fibrillation
    Soeki, T.
    Matsumoto, K.
    Fukuda, D.
    Uematsu, E.
    Matsuura, T.
    Tobiume, T.
    Kusunose, K.
    Ise, T.
    Yamaguchi, K.
    Yagi, S.
    Yamada, H.
    Wakatsuki, T.
    Sata, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 463 - 463
  • [10] Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study
    Fagone, Paolo
    Mangano, Katia
    Basile, Maria Sofia
    Munoz-Valle, Jose Francisco
    Perciavalle, Vincenzo
    Nicoletti, Ferdinando
    Bendtzen, Klaus
    GENES, 2024, 15 (05)